Groton, CT, United States of America

Robert Lee Dow

This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Nimbus Wadjet, Inc., Pfizer Corporation. Active years: 2026.

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 9.6

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Robert Lee Dow

Introduction

Robert Lee Dow is a notable inventor based in Groton, CT (US). He has made significant contributions to the field of innovation, particularly with his work on WRN inhibitors. With a total of 1 patent, Dow's inventions reflect his dedication to advancing technology and improving various applications.

Latest Patents

One of Robert Lee Dow's most recognized patents is related to WRN inhibitors. This invention showcases his expertise and commitment to addressing complex challenges in the scientific community. The patent highlights his innovative approach and the potential impact of his work on future developments.

Career Highlights

Throughout his career, Robert Lee Dow has worked with prominent companies such as Nimbus Wadjet, Inc. and Pfizer Products Inc. His experience in these organizations has allowed him to hone his skills and contribute to significant projects in the pharmaceutical and biotechnology sectors.

Collaborations

Robert Lee Dow has collaborated with talented individuals in his field, including Florian Bartels and Silvana Marcel Leit De Moradei. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions.

Conclusion

In summary, Robert Lee Dow is an accomplished inventor whose work on WRN inhibitors and collaborations with leading companies and professionals have made a lasting impact in his field. His contributions continue to inspire innovation and progress in technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…